BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ali Khan U, Fallah M, Sundquist K, Sundquist J, Brenner H, Kharazmi E. Risk of colorectal cancer in patients with diabetes mellitus: A Swedish nationwide cohort study. PLoS Med. 2020;17:e1003431. [PMID: 33186354 DOI: 10.1371/journal.pmed.1003431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Ding S. The biological and pharmacological connections between diabetes and various types of cancer. Pathol Res Pract 2021;227:153641. [PMID: 34619575 DOI: 10.1016/j.prp.2021.153641] [Reference Citation Analysis]
2 Ottaiano A, Circelli L, Santorsola M, Savarese G, Fontanella D, Gigantino V, Di Mauro A, Capuozzo M, Zappavigna S, Lombardi A, Perri F, Cascella M, Granata V, Capuozzo M, Nasti G, Caraglia M. Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions. Mol Oncol 2021. [PMID: 34668636 DOI: 10.1002/1878-0261.13122] [Reference Citation Analysis]
3 Lee E, Jung SY, Hwang HJ, Jung J. Patient-Level Cancer Prediction Models From a Nationwide Patient Cohort: Model Development and Validation. JMIR Med Inform 2021;9:e29807. [PMID: 34459743 DOI: 10.2196/29807] [Reference Citation Analysis]
4 Done JZ, Fang SH. Young-onset colorectal cancer: A review. World J Gastrointest Oncol 2021; 13(8): 856-866 [PMID: 34457191 DOI: 10.4251/wjgo.v13.i8.856] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Scherübl H. [Type-2-diabetes and cancer risk]. Dtsch Med Wochenschr 2021;146:1218-25. [PMID: 34521128 DOI: 10.1055/a-1529-4521] [Reference Citation Analysis]
6 Tedjasaputra TR, Hatta M, Massi MN, Natzir R, Bukhari A, Masadah R, Parewangi ML, Prihantono P, Nariswati R, Tedjasaputra V. Prediction of hereditary nonpolyposis colorectal cancer using mRNA MSH2 quantitative and the correlation with nonmodifiable factor. World J Gastrointest Pathophysiol 2021; 12(6): 130-142 [DOI: 10.4291/wjgp.v12.i6.130] [Reference Citation Analysis]
7 Qu R, Ma Y, Tao L, Bao X, Zhou X, Wang B, Li F, Lu S, Tuo L, Zhan S, Zhang Z, Fu W. Features of colorectal cancer in China stratified by anatomic sites: A hospital-based study conducted in university-affiliated hospitals from 2014 to 2018. Chin J Cancer Res 2021;33:500-11. [PMID: 34584375 DOI: 10.21147/j.issn.1000-9604.2021.04.07] [Reference Citation Analysis]
8 Tedjasaputra TR, Hatta M, Massi MN, Natzir R, Bukhari A, Masadah R, Parewangi ML, Prihantono P, Nariswati R, Tedjasaputra V. Prediction of hereditary nonpolyposis colorectal cancer using mRNA MSH2 quantitative and the correlation with nonmodifiable factor. World J Gastrointest Pathophysiol 2021; 12(6): 134-146 [PMID: 34877027 DOI: 10.4291/wjgp.v12.i6.134] [Reference Citation Analysis]
9 Shang S, Yang YW, Chen F, Yu L, Shen SH, Li K, Cui B, Lv XX, Zhang C, Yang C, Liu J, Yu JJ, Zhang XW, Li PP, Zhu ST, Zhang HZ, Hua F. TRIB3 reduces CD8+ T cell infiltration and induces immune evasion by repressing the STAT1-CXCL10 axis in colorectal cancer. Sci Transl Med 2022;14:eabf0992. [PMID: 34985967 DOI: 10.1126/scitranslmed.abf0992] [Reference Citation Analysis]
10 Scherübl H. Excess Body Weight and Gastrointestinal Cancer Risk. Visc Med 2021;37:261-6. [PMID: 34540941 DOI: 10.1159/000515444] [Reference Citation Analysis]